Myocarditis and pericarditis in patients with COVID-19
COVID-19 has been associated with a variety of cardiac manifestations. Myocarditis and pericarditis have been reported as one of the many cardiac manifestations in association with COVID-19. We describe below three cases of myocarditis, pericarditis with associated pericardial effusion and myoperica...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2020-01-01
|
| Series: | Heart Views |
| Subjects: | |
| Online Access: | http://www.heartviews.org/article.asp?issn=1995-705X;year=2020;volume=21;issue=3;spage=209;epage=214;aulast=Shah |
| _version_ | 1819169741529415680 |
|---|---|
| author | Jassim Zaheen Shah Smitha Anil Kumar Ashfaq Ahmad Patel |
| author_facet | Jassim Zaheen Shah Smitha Anil Kumar Ashfaq Ahmad Patel |
| author_sort | Jassim Zaheen Shah |
| collection | DOAJ |
| description | COVID-19 has been associated with a variety of cardiac manifestations. Myocarditis and pericarditis have been reported as one of the many cardiac manifestations in association with COVID-19. We describe below three cases of myocarditis, pericarditis with associated pericardial effusion and myopericarditis, respectively, in the setting of COVID-19. Although these entities may occur in isolation, they often occur in association to varying degrees. It could either be the initial diagnosis at the time of presentation or it could occur later in the course of COVID-19 infection. Pericarditis may occasionally be associated with significant pericardial effusion and tamponade requiring therapeutic pericardiocentesis. The assessment of pericardial effusion has been found to be exudative and is usually negative for SARS-CoV-2. Treatment of pericarditis with nonsteroidal anti-inflammatory drugs, colchicine, and corticosteroids has proven to be safe in COVID-19. Myocarditis may present with severe left ventricular systolic dysfunction and cardiogenic shock requiring inotropes and mechanical circulatory support. |
| first_indexed | 2024-12-22T19:24:19Z |
| format | Article |
| id | doaj.art-66a3c56c6d8c4658af5e9400932f91db |
| institution | Directory Open Access Journal |
| issn | 1995-705X |
| language | English |
| last_indexed | 2024-12-22T19:24:19Z |
| publishDate | 2020-01-01 |
| publisher | Wolters Kluwer Medknow Publications |
| record_format | Article |
| series | Heart Views |
| spelling | doaj.art-66a3c56c6d8c4658af5e9400932f91db2022-12-21T18:15:17ZengWolters Kluwer Medknow PublicationsHeart Views1995-705X2020-01-0121320921410.4103/HEARTVIEWS.HEARTVIEWS_154_20Myocarditis and pericarditis in patients with COVID-19Jassim Zaheen ShahSmitha Anil KumarAshfaq Ahmad PatelCOVID-19 has been associated with a variety of cardiac manifestations. Myocarditis and pericarditis have been reported as one of the many cardiac manifestations in association with COVID-19. We describe below three cases of myocarditis, pericarditis with associated pericardial effusion and myopericarditis, respectively, in the setting of COVID-19. Although these entities may occur in isolation, they often occur in association to varying degrees. It could either be the initial diagnosis at the time of presentation or it could occur later in the course of COVID-19 infection. Pericarditis may occasionally be associated with significant pericardial effusion and tamponade requiring therapeutic pericardiocentesis. The assessment of pericardial effusion has been found to be exudative and is usually negative for SARS-CoV-2. Treatment of pericarditis with nonsteroidal anti-inflammatory drugs, colchicine, and corticosteroids has proven to be safe in COVID-19. Myocarditis may present with severe left ventricular systolic dysfunction and cardiogenic shock requiring inotropes and mechanical circulatory support.http://www.heartviews.org/article.asp?issn=1995-705X;year=2020;volume=21;issue=3;spage=209;epage=214;aulast=Shahcovid-19cytokine stormmyocarditismyopericarditispericarditissars-cov-2 |
| spellingShingle | Jassim Zaheen Shah Smitha Anil Kumar Ashfaq Ahmad Patel Myocarditis and pericarditis in patients with COVID-19 Heart Views covid-19 cytokine storm myocarditis myopericarditis pericarditis sars-cov-2 |
| title | Myocarditis and pericarditis in patients with COVID-19 |
| title_full | Myocarditis and pericarditis in patients with COVID-19 |
| title_fullStr | Myocarditis and pericarditis in patients with COVID-19 |
| title_full_unstemmed | Myocarditis and pericarditis in patients with COVID-19 |
| title_short | Myocarditis and pericarditis in patients with COVID-19 |
| title_sort | myocarditis and pericarditis in patients with covid 19 |
| topic | covid-19 cytokine storm myocarditis myopericarditis pericarditis sars-cov-2 |
| url | http://www.heartviews.org/article.asp?issn=1995-705X;year=2020;volume=21;issue=3;spage=209;epage=214;aulast=Shah |
| work_keys_str_mv | AT jassimzaheenshah myocarditisandpericarditisinpatientswithcovid19 AT smithaanilkumar myocarditisandpericarditisinpatientswithcovid19 AT ashfaqahmadpatel myocarditisandpericarditisinpatientswithcovid19 |